Microangiopathic Hemolytic Anemia (MAHA) is a type of hemolytic anemia characterized by the destruction of red blood cells (RBCs) due to physical damage when passing through small blood vessels. This condition is often associated with various systemic diseases such as thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), and disseminated intravascular coagulation (DIC).
